Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study [Corrigendum]
Casas A, Montes de Oca M, Menezes AMB, Wehrmeister FC, Lopez Varela MV, Mendoza L, Ramírez L, Miravitlles M. Int J Chron Obstruct Pulmon Dis. 2018;13:1545–1556.Page 1552, Disclosure, the text “AM has been paid for her work as a statistician f...
Main Authors: | Casas A, Montes de Oca M, Menezes AMB, Wehrmeister FC, Lopez Varela MV, Mendoza L, Ramírez L, Miravitlles M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | International Journal of COPD |
Online Access: | https://www.dovepress.com/corrigendum-respiratory-medication-used-in-copd-patients-from-peer-reviewed-article-COPD |
Similar Items
-
Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study
by: Casas A, et al.
Published: (2018-05-01) -
Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.
by: Maria Montes de Oca, et al.
Published: (2017-01-01) -
Respiratory symptoms (COPD Assessment Test and modified Medical Research Council dyspnea scores) and GOLD-ABCD COPD classification: the LASSYC study
by: Maria Montes de Oca, et al.
Published: (2021-11-01) -
External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population
by: Lopez Varela MV, et al.
Published: (2019-08-01) -
Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort
by: Perez-Padilla R, et al.
Published: (2018-10-01)